A condition affecting millions of women worldwide, previously known as PCOS, has been given a new name, with some sources referring to it as Polyendocrine Metabolic Ovarian Syndrome or PMOS. The name change is intended to improve diagnosis and care, but it is unclear if all sources agree on the new terminology. The condition appears to be impacting a significant portion of women, with estimates suggesting it affects one in eight women, although the brief does not provide information on the condition's symptoms or effects.